HIV drug resistance mutations following poor adherence in HIV ‐infected patient: a case report-Reference-Cited by-同舟云学术

HIV drug resistance mutations following poor adherence in HIV ‐infected patient: a case report

Published:2015-03-29 Issue:6 Volume:3 Page:353-356
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Masikini Peter¹²,Mpondo Bonaventura C. T.³

Affiliation:

1. Department of Internal Medicine Bugando Medical Centre Mwanza Tanzania

2. Department of Internal Medicine Catholic University of Health and Allied Sciences Mwanza Tanzania

3. Department of Internal Medicine College of Health Sciences The University of Dodoma Dodoma Tanzania

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.254

Reference12 articles.

1. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

2. UNAIDS.Global AIDS epidemic facts and figures[Internet].2012. Available at:http://www.unaids.org/en/resources/presscentre/factsheets/(accessed 3 October 2014).

3. The President's Emergency Plan for AIDS Relief in Africa: An Evaluation of Outcomes

4. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustainability of Global Fund Grants;Stakeholder Relationships And Sustainability;2023-10-20

2. HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy;mBio;2022-06-28

3. Effects of psychosocial factors on nonadherence to ART in Ganta, Nimba county, Liberia;AIDS Research and Therapy;2022-06-25

4. Magnitude and predictors of HIV-Drug resistance in Africa: A protocol for systematic review and meta-analysis;PLOS ONE;2022-04-20

5. Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study;Expert Review of Anti-infective Therapy;2022-01-04